ReviewVideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy2026
Usability of a novel cholangiopancreatoscope for tumor detection and stone management.
Review in VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Peroral cholangiopancreatoscopy (POCP) is increasingly used in complex ERCP but remains limited by small working channels and maneuverability challenges. This case series describes early user experience with a novel single-use POCP system for evaluation of indeterminate biliary strictures and electrohydraulic lithotripsy (EHL) of pancreatic and biliary stones. Methods: A case series included individuals undergoing evaluation for indeterminate biliary strictures and complex stone management. Procedures were evaluated for technical success, usability (Likert scale), diagnostic yield, and adverse events (AEs). Results: Twelve patients were included. Among the 9 who underwent cholangioscopy-directed biopsy samples, all provided adequate tissue. Of 6 malignancies, none were diagnosed by brush cytology, whereas cholangioscopy-directed biopsy samples were diagnostic in 4 of 5 cases of cholangiocarcinoma and 1 case of hepatocellular carcinoma. In all 3 stone cases, a 4.5F (catheter/probe size unit; 1F = 0.33 mm) EHL probe was successfully advanced, achieving complete stone clearance in a single session. Five endoscopists performed the procedures, reporting high Likert scores for pushability, tip control, device passage, and image quality. No periprocedural AEs were noted. Conclusions: In this limited single-center, noncomparative experience, the system enabled tissue sampling and EHL with reported ease of use. These preliminary findings should be interpreted cautiously and in the context of standard ERCP risks, including pancreatitis, infection, perforation, and cholangitis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.